SUMMARY We performed a prospective anatomic validation study to determine the accuracy of left ventricular (LV) mass estimates from clinical two-dimensional echocardiographic (2-D echo) studies. In 21 subjects, antemortem 2-D echo LV mass determinations were compared with anatomic LV weight by postmortem chamber dissection. Major cardiac diagnoses included anatomic LV aneurysm in four, status post aneurysmectomy in one, transmural myocardial infarction in seven, congestive cardiomyopathy in five, rheumatic mitral disease in two, chronic severe mitral or aortic regurgitation in three, amyloid heart in two, and normal heart in three. Marked right-heart dilatation was present in 11 patients and LV thrombus in four. Regression equations derived in vitro for each 2-D echo instrument were used to correct LV mass estimates based on a short-axis, area-length method: uncorrected LV mass = 1.055 x k x 5/6 (AtLt -ACLC) + b, where At = total short-axis LV image area at the high papillary muscle level, Lc = endocardial LV length, k = an instrument-specific regression slope and b = an instrument-specific and 2-D echo have been only fair to good, but this may be due to errors in both techniques. In considering the development of methods for 2-D echo estimation of LV mass, we made the following postulates. First, short-axis imaging should usually provide optimal resolution of endocardial and epicardial boundaries because the angle of incidence of the echo beam is relatively favorable. Second, a clinically useful method must be simple to perform. Third, the relationship between 2-D echo image area and actual cardiac target area must be critically examined and quantitatively expressed. Fourth, direct comparisons of echo LV mass and postmortem LV weight would give more reliable results than angiographic comparisons. Therefore, we developed an in vitro method of imaging postmortem short-axis human heart slices to test 2-D image accuracy and used it to evaluate a simple short- axis, area-length method for determining LV mass by 2-D echo.5 From these studies, we developed regression equations to correct 2-D echo images obtained with six types of 2-D echo instrument.6 Based on our in vitro results, the present study was designed as a prospective test of the reliability of LV mass estimates derived from clinical 2-D echo images by the regression-corrected, short-axis, area-length method compared with postmortem LV weight.
TWO-DIMENSIONAL echocardiography (2-D echo)
is a promising method for noninvasive quantitation of left ventricular (LV) volume and myocardial mass in man.A4 However, there is little information on the accuracy of 2-D echo images of actual cardiac targets. Moreover, validation of 2-D echo methods has relied heavily on other indirect methods, such as angiography.iA Reported correlations between angiography and 2-D echo have been only fair to good, but this may be due to errors in both techniques. In considering the development of methods for 2-D echo estimation of LV mass, we made the following postulates. First, short-axis imaging should usually provide optimal resolution of endocardial and epicardial boundaries because the angle of incidence of the echo beam is relatively favorable. Second, a clinically useful method must be simple to perform. Third, the relationship between 2-D echo image area and actual cardiac target area must be critically examined and quantitatively expressed. Fourth, direct comparisons of echo LV mass and postmortem LV weight would give more reliable results than angiographic comparisons. Therefore, we developed an in vitro method of imaging postmortem short-axis human heart slices to test 2-D image accuracy and used it to evaluate a simple short-axis, area-length method for determining LV mass by 2-D echo.5 From these studies, we developed regression equations to correct 2-D echo images obtained with six types of 2-D echo instrument.6
Based on our in vitro results, the present study was designed as a prospective test of the reliability of LV mass estimates derived from clinical 2-D echo images by the regression-corrected, short-axis, area-length method compared with postmortem LV weight.
Methods
From January 1, 1979, to December 31, 1981, 21 subjects who had undergone high-quality 2-D echo studies with Varian 3000R or 3400 phased-array instruments came to autopsy. The mean interval from 2-D echo to death was 21 days (range 2-76 days). Four subjects had anatomic LV aneurysms and one had undergone an aneurysmectomy. Seven subjects had had transmural myocardial infarction. Five subjects had congestive cardiomyopathy, two rheumatic mitral disease, three chronic severe mitral or aortic regurgitation, two cardiac amyloidosis, and three had normal hearts. Sixteen had congestive heart failure, three mitral prostheses, one an aortic prosthesis, three clinical or angiographic evidence of severe nonrheumatic mitral regurgitation and 11 right-heart dilatation and failure. LV mural thrombus was present in four patients and occupied most of the LV cavity in one patient.
In 18 hearts, LV weight was determined by the chamber dissection method of Bove and co-workers,7 which includes septal weight. Epicardial fat was removed and 3% was subtracted from LV weight to accounit for effects of foiinalin fixation.' three hearts were distended at physiologic pressure, fixed, embedded in gelatin, and the LV was sliced at 5-mm intervals. Manually digitized outlines of myocardial and cavity boundaries were used in computer reconstruction of myocardial mass. 9 M-mode echo data were available in 18 subjects for estimation of M-mode LV mass by our previously reported regression-corrected, modified cube method, which has been validated by comparison with both LV weight and angiographic LV mass for hearts without marked asymmetry. 10 Four hearts were subsequently divided into shortaxis sections and reimaged in vitro by our previously reported method. Uncorrected in vitro area-length LV mass and uncorrected in vivo mass correlated well (r = 0.92, slope = 0.93, intercept = 80 g). and for evaluating different geometric models in detail. However, short-axis images also contain less geometric information about LV shape than do long-axis or apical four-chamber or two-chamber views. Simpson's rule approximations can be made with short-axis images only by obtaining serial images spaced along the long-axis of the ventricle. The number of such images required for optimal imaging in dogs has been shown by Eaton and co-workers"5 to be at least six. Unfortunately, in the clinical setting, it is rarely possible to obtain so many serial short-axis images. Wyatt and co-workers'2' 14 showed in dogs that a simple arealength method, based on a single short-axis section at the high papillary muscle level, combined with apical LV length gives estimates of LV mass and volume nearly as accurate as those obtained with Simpson's rule in both symmetric and asymmetric ventricles. We verified this for in vitro imaging of human hearts of normal shape and those with marked shape abnormalities.5 The excellent correlation between 2-D echo LV mass and postmortem LV weight in the present prospective series, which also contained many markedly distorted hearts (four with aneurysm, four with LV thrombus and 11 with marked right-heart enlargement) shows that both the regression correction and the geometric validation derived from in vitro studies have clinical applicability. Presumably, use of a short-axis image at the papillary muscle level at approximately the midpoint in LV length and reliance on end-diastolic images obtained at the time in the cardiac cycle when LV shape is least distorted in ischemic heart disease contribute to the success of this approach. The method also measures LV length directly with axial resolution. Despite the geometric limitations of short-axis imaging, the results appear to be more satisfactory than those previously obtained in man using only apical views in a study validated by biplane angiography.' Nonetheless, with continued improvement in image characteristics, it will probably be possible to obtain still more reliable results using four-and two-chamber views.
Whatever views are to be used for quantitative imaging, the results obtained in both our earlier in vitro studies and in the present study suggest that overestimation of myocardial area and underestimation of LV cavity area may be consistent features of 2-D echo images, although quantitatively different for different types of 2-D instrument. The preliminary reports of Barrett and co-workers6' 17 also support this view. We have also noted that the differences in regression equations obtained with different instruments of varying design require use of instrument-specific equations. 6 Whether each instrument will require individual calibration of this type has not yet been determined, but it is encouraging that two studies in this series were accurately assessed using a regression correction derived from another instrument of the same design.
Because of the difficulty of obtaining appropriately timed 2-D echo studies and corresponding postmortem data, the number of hearts studied to date is limited.
However, the regression slope, standard error and correlation coefficient have not changed appreciably since the results were analyzed for the first eight hearts. Furthermore, when in vitro and in vivo data are combined, 34 comparisons of echo results and LV weight have been made, a number similar to those available for biplane angiography.S' 8 Nonetheless, our results must be confirmed by additional data obtained in our own and other laboratories before assessment of the method is complete. In that effort, it may be necessary to individually calibrate each instrument with in vitro image data until the degree of sample variation between 2-D instruments of the same design and the impact of different user techniques can be more thoroughly assessed.
The overall significance of our data is best appreciated in the context of alternative methods for estimating LV mass. The results of Kennedy et al.8 for biplane angiography indicate that biplane angiographic LV mass, as compared with postmortem LV weight, gave a correlation coefficient of 0.97 and a standard error of 32 g. However, large errors were noted in patients with marked right ventricular hypertrophy, who were excluded from the analysis. Patients with pericardial effusion or thickening and hypertrophic cardiomyopathy were also excluded. Furthermore, no patients with ischemic heart disease were studied and none had an LV thrombus.
Our previous M-mode echo validation study by comparison to LV weight gave statistical results very similar to those of the angiographic method.`' Unlike the angiographic method, the M-mode method was evaluated in 12 hearts with myocardial infarction. However, that series did not, by chance, include hearts with major geometric distortions due to LV aneurysm, mural thiombus or marked right-heart enlargement. All of these abnormalities were prevalent in the present study, in part because of a change in our institution's patient population in the last 6 years. As our present data demonstrate, M-mode estimates of LV mass in more distorted hearts are less accurate than in the more symmetric hearts previously studied. Despite the more challenging geometry of the hearts in this series, 2-D echo gave reliable results, with a correlation coefficient and standard error comparable to those previously reported with either of the older techniques, over a smaller range of LV weights. The superiority of these results to the M-mode results in the present study probably are explained in part by the inaccuracy of the Mmode cube formula assumption of an LV length/diameter ratio for this population. A second factor appeared to be improved estimation of mean myocardial thickness by the 2-D area technique. Thus, because of its insensitivity to LV shape abnormalities, our 2-D method may improve the reliability of LV mass estimates used in clinical research and the understanding of the role of LV hypertrophy in common disorders that alter LV hemodynamic load or contractility.
We conclude that 2-D echo short-axis area-length estimates of LV mass, when corrected for the specific 351 VOL 67, No 2, FEBRUARY 1983 image area properties of the 2-D echo instrument used, appear to provide simple, reliable estimates of in vivo LV mass despite marked abnormalities of LV shape. Further data from other laboratories will be required to determine the ultimate value of this promising method.
